Search Results 721-730 of 17568 for Assay

  1. A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery - Mayo Clinic

    older than 6 weeks as documented by a local laboratory using standard assay methodology. - Non-emergent open chest cavity major cardiopulmonary bypass (CPB) ...

  2. Glomerulonephritis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to develop and validate full gene-sequencing assays or known mutation sequencing assays for the evaluation of patients with ...

  3. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

    Biopsy evaluable for expression of PD-L1 as determined by a PD-L1 Immunohistochemistry (IHC) pharma diagnostic test (pharmDx) assay performed by a central ...

  4. Thyroid Autoimmunity Biobank - Clinical Trials

    TPO antibodies >9 IU/L or ULN for the assay; US pattern or cytology or pathology consistent with HT. Graves' Orbitopathy. ≥18 years of age; Presence of ...

  5. Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) - Mayo Clinic

    * Participant has documented HIV infection by any licensed assay or documented history of detectable HIV-1 RNA. * Participant is ≥ 18 years old. * Cluster ...

  6. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  7. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  8. A Study of Study of Immune Tolerance Mechanisms in Kidney Transplant Patients - Mayo Clinic

    Subjects diagnosed with the Human Immunodeficiency Virus (HIV), or who have tested positive for HIV documented by any licensed ELISA assay and confirmed by ...

  9. Testing Low Dose Tamoxifen For Invasive Breast Cancer, The (LoTam) Trial - Mayo Clinic

    ... assay was obtained, both are required to be low-risk): * Oncotype DX recurrence score ≤ 25 * Mamma Print low risk * Prosigna risk of recurrence ≤ 40 * ...

  10. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA) - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC assay ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65). Participants with relapsed ...